 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Nomination and Remuneration / Compensation Committee of Aurobindo Pharma Ltd on March 09, 2017 has allotted 6,97,823 equity shares of Re. 1/- each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 58,51,69,586 Equity Shares of Re. 1/- each to 58,58,67,409 Equity Shares of Re. 1/- each.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.658.25 as compared to the previous close of Rs. 666.05. The total number of shares traded during the day was 123065 in over 4196 trades.
The stock hit an intraday high of Rs. 667.1 and intraday low of 655. The net turnover during the day was Rs. 81316747.